Contact Points
Buffalo Grove, IL 60089
The purpose of this acquisition is to acquire a service agreement (maintenance/repairs) for a Leica Aperio Versa digital pathology scanner. The National Center for Advancing Translational Sciences (NCATS) Division of Preclinical Innovation (DPI) Tissue Bioprinting Laboratory (TBPL) provides NCATS investigators with access to a Leica Aperio Versa which is a comprehensive digital pathology scanner capable of visualizing engineered tissues. This Unit supports research resulting in high quality images on demand for tissue-based screening, disease model and assay development. The Leica Aperio Versa in this laboratory is a critical component in carrying out its mission, which builds on internal expertise at NCATS in assay development for drug screening, automation technologies, stem cell biology, tissue engineering and advanced high-content microscopy. Furthermore, the Leica Aperio Versa is utilized by NCATS in pursuit of their ongoing research projects. A service agreement allows for quick repair, if needed and regular maintenance and upgrading work to ensure continued use of the equipment which is required to perform at peak manufacturer’s standards.
Interested parties may identify in writing their interest and capability in response to this requirement. Responses to this notice shall contain sufficient information to establish the interested parties’ bona-fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.
All responses must be received by closing date and must reference the announcement. Responses may be submitted electronically to the attention of the contract specialist. Fax responses will not be accepted.
All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency.